UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 39

of 'Adjuvant chemotherapy for resected stage II colon cancer'

39
TI
Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
AU
Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H
SO
Ann Surg Oncol. 2008;15(12):3433. Epub 2008 Oct 10.
 
BACKGROUND: We evaluated the prognostic value of the preoperative serum carcinoembryonic antigen (CEA) level in patients with colorectal cancer (CRC).
PATIENTS AND METHODS: The study group comprised 638 patients. The optimal cutoff value for the preoperative serum CEA level was determined. Predictive factors of recurrence were evaluated using multivariate analyses. The relapse-free time was investigated according to the CEA level.
RESULTS: All patients underwent potentially curative resection for CRC without distant metastasis, classified as stage I, II, or III. The optimal cutoff value for preoperative serum CEA level was 10 ng/ml. Elevated preoperative serum CEA level was observed in 92 patients. Multivariate analysis identified tumor-node-metastasis (TNM) stage and preoperative serum CEA level as independent predictive factors of recurrence. The relapse-free survival between CEA levels>10 ng/ml and<10 ng/ml significantly differed in patients with stage II and III. However, there was no significantdifference in relapse-free survival between CEA levels>10 ng/ml and<10 ng/ml in patients with stage I.
CONCLUSION: Preoperative serum CEA is a reliable predictive factor of recurrence after curative surgery in CRC patients and a useful indicator of the optimal treatment after resection, particularly for cases classified as stage II or stage III.
AD
Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan. rtakagawa@gmail.com
PMID